Latest European Medicines Agency Stories
US Submission Designed to Support Conversion From Accelerated to Full FDA Approval and Expansion of Current Approved Indication THOUSAND OAKS, Calif.
TARRYTOWN, N.Y. and PARIS, Jan. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
-- First biosimilar from Samsung Bioepis to advance to EMA regulatory review -- INCHEON, South Korea, Jan.
TARRYTOWN, N.Y. and PARIS, Jan.
LONDON, January 8, 2015 /PRNewswire/ -- EMA's Committee for Orphan Medicinal Products recommends Magnus Growth Therapy for Placental Insufficiency
LONDON, January 7, 2015 /PRNewswire/ -- ~ Shield seeks approval of Feraccru for the treatment of iron deficiency
NiCord® is in clinical development as a treatment for blood cancers including leukemia and lymphoma JERUSALEM, January 6, 2015 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com
LEXINGTON, Mass., Dec.
LYNBROOK, N.Y., Dec. 22, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
CALGARY, Dec. 22, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.